Investigational Drug May Prolong Survival in Patients With ALS

TUESDAY, Oct. 20, 2020 -- Long-term survival analysis shows that patients with earlier initiation of sodium phenylbutyrate-taurursodiol (PB-TURSO) treatment for amyotrophic lateral sclerosis (ALS) have longer median overall survival, according to a...

Source: Drugs.com - Pharma News - October 20, 2020 Category: Pharmaceuticals Source Type: news